HFS
ADMA icon

Hantz Financial Services’s ADMA Biologics ADMA Stock Holding History

Hantz Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Buy
3,989
+2,904
+268% +$45.8K ﹤0.01% 1665
2025
Q4 		$20K Buy
1,085
+270
+33% +$4.55K ﹤0.01% 1783
2025
Q3 		$12K Buy
815
+467
+134% +$8.01K ﹤0.01% 1750
2025
Q2 		$6K Buy
348
+328
+1,640% +$6.69K ﹤0.01% 1665
2025
Q1 		$0 Buy
+20
New +$346 ﹤0.01% 1655

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hantz Financial Services's ADMA Position: Q1 2026 in Review

Hantz Financial Services increased its ADMA Biologics (ADMA) stake by 268% in Q1 2026, buying an estimated $45.8K and bringing the position to 3,989 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Hantz Financial Services first reported a position in ADMA in Q1 2025 and has held it in 5 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Hantz Financial Services held 3,989 shares of ADMA Biologics worth $36K as of Q1 2026.
  • Hantz Financial Services bought 2,904 ADMA Biologics shares in Q1 2026, an estimated $45.8K.
  • ADMA Biologics made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #1665 holding.
  • Hantz Financial Services first reported a position in ADMA Biologics in Q1 2025 and has held it in 5 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.